https://european-biotechnology.net/wp-content/uploads/2024/10/ikerian-1030x584-1.png5841030Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2024-10-16 13:25:442024-10-16 13:25:44Swiss Ikerian AG partner with Sanoptis Inc to market AI-image analysis
https://european-biotechnology.net/wp-content/uploads/2024/10/Molcure-e1729083269678-1030x578-1.png5781030Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2024-10-16 12:55:562024-10-16 12:55:56Antibody developer Yumab partners with Japanese AI specialist Molcure
https://european-biotechnology.net/wp-content/uploads/2024/10/Lundbecks-headquarters-in-Valby-e1728977732319-1030x580-1.jpeg5801030Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2024-10-15 07:36:572024-10-15 07:36:57Lundbeck to take over Longboard Pharma in US$2.6bn transaction
https://european-biotechnology.net/wp-content/uploads/2024/10/PenkidMOA.png326554Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2024-10-09 08:57:572024-10-09 08:57:57Sphingotec licenses kidney function test
https://european-biotechnology.net/wp-content/uploads/2024/10/lung-freepik-ai-20241008-1030x579-1.jpeg5791030Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2024-10-08 12:45:282024-10-08 12:45:28Vicore secures funding to accelerate drug development
https://european-biotechnology.net/wp-content/uploads/2024/10/Scotland-1030x618-1.jpg6181030Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2024-10-03 07:25:302024-10-03 07:25:30Kurma closes new fund at €250m
